SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-036375
Filing Date
2023-11-02
Accepted
2023-11-02 16:02:08
Documents
48
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20230930.htm   iXBRL 10-Q 882648
2 EX-31.1 crdf-093023exhibit311.htm EX-31.1 10718
3 EX-31.2 crdf-093023exhibit312.htm EX-31.2 10688
4 EX-32.1 crdf-093023exhibit321.htm EX-32.1 6126
5 EX-32.2 crdf-093023exhibit322.htm EX-32.2 6096
  Complete submission text file 0001628280-23-036375.txt   4492971

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230930.xsd EX-101.SCH 24626
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20230930_cal.xml EX-101.CAL 59235
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20230930_def.xml EX-101.DEF 109236
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230930_lab.xml EX-101.LAB 463782
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230930_pre.xml EX-101.PRE 268576
42 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230930_htm.xml XML 627747
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 231372070
SIC: 2836 Biological Products, (No Diagnostic Substances)